Status:
NOT_YET_RECRUITING
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Hip Osteoarthritis
Hip Arthropathy
Eligibility:
All Genders
65-100 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to evaluate whether different types of regional anesthesia can improve pain control and functional recovery after total hip arthroplasty in adult patients undergoing...
Detailed Description
Total hip arthroplasty (THA) is associated with moderate-to-severe postoperative pain, which can impair early mobilization and functional recovery. Regional anesthesia techniques, such as the pericaps...
Eligibility Criteria
Inclusion
- Age ≥ 65 years
- ASA physical status I-III
- Elective unilateral THA via posterior or lateral approach
- Informed consent provided
Exclusion
- Allergy to study drugs (ropivacaine, dexamethasone)
- Chronic opioid use (\>30 MME/day)
- Coagulopathy or infection at the injection site
- BMI \> 40 kg/m²
- Pre-existing motor weakness or neuropathy in the affected limb
- Cognitive impairment precluding informed consent
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07180979
Start Date
October 1 2025
End Date
November 30 2026
Last Update
September 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.